HBA1C TARGET SETTING IS ASSOCIATED WITH METABOLIC CONTROL
dc.contributor.author | Van Loocke, M. | |
dc.contributor.author | Battelino, T. | |
dc.contributor.author | Tittel, S. | |
dc.contributor.author | Prahalad, P. | |
dc.contributor.author | Goksen, D. | |
dc.contributor.author | Davis, E. | |
dc.contributor.author | Casteels, K. | |
dc.date.accessioned | 2020-12-01T12:04:49Z | |
dc.date.available | 2020-12-01T12:04:49Z | |
dc.date.issued | 2020 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | [No abstract available] | en_US |
dc.identifier.endpage | A237 | en_US |
dc.identifier.issn | 1520-9156 | |
dc.identifier.issn | 1557-8593 | |
dc.identifier.startpage | A237 | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/62755 | |
dc.identifier.volume | 22 | en_US |
dc.identifier.wos | WOS:000514025300602 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Mary Ann Liebert, Inc | en_US |
dc.relation.ispartof | Diabetes Technology & Therapeutics | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | HBA1C TARGET SETTING IS ASSOCIATED WITH METABOLIC CONTROL | en_US |
dc.type | Conference Object | en_US |